Trials / Unknown
UnknownNCT03081741
Circulating Tumor DNA in Surgical Lung Cancer Patients
A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Lung Cancer Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Shenzhen Gene Health Bio Tech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Conduct a prospective study to detect the change of ctDNA of surgical lung cancer patients.
Detailed description
Studies have shown the feasibility of detecting mutation status by blood circulating tumor DNA (ctDNA) in lung cancer patients. The investigators plan to test the blood ctDNA in surveillance of surgical lung cancer patients. And evaluate the correlation between ctDNA level with tumor relapse or metastasis.
Conditions
Timeline
- Start date
- 2017-05-03
- Primary completion
- 2017-12-01
- Completion
- 2020-03-18
- First posted
- 2017-03-16
- Last updated
- 2017-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03081741. Inclusion in this directory is not an endorsement.